Chevalier et al. demonstrated an association between NT-proBNP levels and CMR-derived variables (LAV, LVM measured as septal wall thickness and scar volume in grams) in patients with hypertrophic cardiomyopathy [22]. Here, NPPB is linked to hypertrophic cardiomyopathy.